Generated by GPT-5-mini| CAGE | |
|---|---|
| Name | CAGE |
| Type | Assessment questionnaire |
| Developer | Ewing |
| Introduced | 1968 |
| Domain | Alcohol screening |
CAGE
CAGE is a brief screening instrument used to detect potential problematic alcohol use and alcohol dependence in clinical and research settings. It is widely cited across studies by clinicians, psychiatrists, addiction specialists, and public health organizations for its brevity and prognostic utility. The tool has been used in diverse contexts involving patients seen by physicians, surgeons, psychiatrists, and emergency medicine practitioners, and is commonly referenced in guidelines from organizations addressing substance use and mental health.
The instrument consists of four dichotomous items derived to identify signs associated with alcohol-related problems: Cut down, Annoyed, Guilty, and Eye-opener. It was designed for quick administration in primary care, inpatient, and outpatient settings and has been compared against diagnostic interviews produced by psychiatry and addiction medicine authorities. The CAGE items are intended to screen for lifetime patterns compatible with alcohol dependence and have been evaluated across populations studied by organizations such as the World Health Organization, Centers for Disease Control and Prevention, and various university medical centers.
CAGE originated from clinical research in the late 1960s by a psychiatrist seeking efficient methods for case finding among patients presenting to medical services. Early validation studies compared the instrument to structured interviews used by addiction researchers and clinical epidemiologists. Over subsequent decades, investigators at institutions such as Yale, Johns Hopkins, and University College Dublin assessed psychometric properties, leading to citations in influential reports from bodies like the American Psychiatric Association and the Royal College of Physicians. Subsequent adaptations and translations were performed by researchers affiliated with hospitals and universities across Europe, North America, and Asia.
The four items each correspond to a mnemonic word: Cut down, Annoyed, Guilty, Eye-opener. Each item is a single yes/no question aimed at detecting behavior patterns clinicians have associated with alcohol misuse in case series and cohort studies. Scoring conventions emerged from early epidemiological work, with cutoffs used in prevalence studies conducted by public health institutes and medical schools. The questionnaire’s brevity made it attractive for inclusion in larger assessment batteries developed at teaching hospitals and research centers, alongside instruments produced by psychiatric associations and addiction research groups.
As a screening instrument, CAGE functions by eliciting reported experiences that cluster with diagnostic criteria articulated in nosological systems promulgated by psychiatric organizations. Affirmative responses on the items statistically correlate with diagnoses yielded by structured diagnostic interviews administered in clinical trials and cohort studies led by academic medical centers and research consortia. The instrument does not measure quantity or frequency per se but targets behavioral and affective indicators that have been associated with neurobiological and psychosocial models explored by neuroscientists and social epidemiologists at research institutes and universities.
Clinicians in primary care clinics, emergency departments, surgical wards, and psychiatric units routinely use the instrument as part of initial assessments, preoperative evaluations, and population health screenings. Health systems and academic hospitals often include it in intake protocols and research protocols alongside structured diagnostic tools used by psychologists and psychiatrists. Public health agencies and nonprofit organizations involved in addiction services have incorporated the instrument into screening programs, while clinical trials at medical research centers have used it as an eligibility or stratification measure. It has also been adapted for use in occupational health settings, veteran health services, and community-based screening initiatives coordinated by charities and municipal health departments.
As a questionnaire, the instrument is not regulated as a medical device by agencies that oversee pharmaceuticals and devices, but its use falls under clinical practice guidelines and institutional review policies established by hospitals, universities, and professional colleges. Ethical oversight for research involving the tool is typically provided by institutional review boards at academic institutions and research hospitals, and professional guidelines from psychiatric and addiction medicine associations address appropriate use and referrals following a positive screen. Quality assurance in clinical services is maintained through training programs run by medical schools, professional societies, and continuing medical education providers to ensure reliable administration and appropriate follow-up care.
Category:Screening tools for substance use